Abstract
A rapid, sensitive, and specific method based on liquid chromatography/tandem mass spectrometry (LC-MS/MS) was developed and validated for the determination of propranolol in human plasma using metoprolol as internal standard. The drugs were extracted from plasma by liquid-liquid extraction and separated isocratically on a Phenomenex Synergi Fusion-RP C18 analytical column, 4 µm (150 mm × 4.6 mm i.d.) maintained at 30°C, with acetonitrile/water (95/5, v/v): 100 mM ammonium acetate: 100 mM acetic acid (65:15:20 v/v/v) as mobile phase, run at a flow rate of 1 mL min−1 (split 1:3). Detection was carried out by positive electrospray ionization (ESI +) in selected reaction monitoring (SRM) mode. The chromatographic separation was obtained within 3.0 min and was linear in the concentration range of 2–150 ng mL−1 (r2 = 0.9969). The method was successfully applied for the bioequivalence study of two tablet formulations (test and reference) of propranolol 80 mg after single oral dose administration to 36 healthy human volunteers, using an open, randomized, two period crossover design with one week wash out interval.The geometric means ratios of C max and AUC(0-∞) were 99.77 and 103.70%, respectively, with both the confidence intervals between 90.12–112.92% demonstrating the bioequivalence of the two formulations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Liquid Chromatography & Related Technologies
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
